Cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) Infusion Therapy
Our Therapies

Cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) Infusion Therapy

Meet our Infusion Specialists

  • Jalal Thwainey M.D.

    Jalal Thwainey M.D.

    Medical Director

  • Randy Josey

    Randy Josey

    Director of Partnerships

For Provider

Simplify patient referrals and offer advanced treatment options with our infusion partnership program.

For Patient

There may be a better way to manage your condition – explore infusion therapy.

logo

Cutting-edge infusion therapies and injections for patients with complex chronic conditions and rare diseases.

instagramfacebooklinkedinTwitter

© 2025 violet health®: Infusion Care. All rights reserved.